Heng Ni1, Lin-Bo Zhao1, Sheng Liu1, Zhen-Yu Jia1, Yue-Zhou Cao1, Hai-Bin Shi2. 1. Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China. 2. Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China. shihb@njmu.edu.cn.
Abstract
PURPOSE: Before we enter the era of flow diverter stents (FDS), the standard stent-assisted coiling technique is a well-established treatment option for routine paraclinoid aneurysms. We assess the clinical safety and efficacy of stent-assisted coiling with open-cell stent in the treatment of paraclinoid aneurysms and evaluate the association between clinical factors and follow-up aneurysm occlusion. METHODS: The clinical and radiographic data of 110 consecutive patients with 122 paraclinoid aneurysms treated with open-cell stent between April 2015 and April 2019 were analyzed retrospectively at our center. We assessed the immediate and progressive occlusion rates, complications, and clinical outcome. Multivariate analysis was performed to investigate the risk factors of angiographic incomplete occlusion. RESULTS: Among 110 patients, stent-assisted coiling was successfully performed in all cases. Four (3.6%) thromboembolic events were reported during the procedure, which resulted in transient morbidity. Immediate angiography demonstrated complete occlusion in 64 (52.5%) aneurysms and no occlusion of ophthalmic artery. Angiographic follow-up at 6 months demonstrated an increase in the complete occlusion rate to 92.9%. No delayed in-stent stenosis was observed, and three aneurysms recurred. Clinical follow-up was completed in 102 patients (92.7%), and favorable outcomes were achieved in 101 (99%) patients at 6 months. Multivariate analysis showed that aneurysm size (p < 0.001) was associated with incomplete aneurysm occlusion at follow-up. CONCLUSION: Stent-assisted coil embolization with open-cell stents is safe and effective for the treatment of paraclinoid aneurysms and provides progressive occlusion without significant in-stent stenosis events.
PURPOSE: Before we enter the era of flow diverter stents (FDS), the standard stent-assisted coiling technique is a well-established treatment option for routine paraclinoid aneurysms. We assess the clinical safety and efficacy of stent-assisted coiling with open-cell stent in the treatment of paraclinoid aneurysms and evaluate the association between clinical factors and follow-up aneurysm occlusion. METHODS: The clinical and radiographic data of 110 consecutive patients with 122 paraclinoid aneurysms treated with open-cell stent between April 2015 and April 2019 were analyzed retrospectively at our center. We assessed the immediate and progressive occlusion rates, complications, and clinical outcome. Multivariate analysis was performed to investigate the risk factors of angiographic incomplete occlusion. RESULTS: Among 110 patients, stent-assisted coiling was successfully performed in all cases. Four (3.6%) thromboembolic events were reported during the procedure, which resulted in transient morbidity. Immediate angiography demonstrated complete occlusion in 64 (52.5%) aneurysms and no occlusion of ophthalmic artery. Angiographic follow-up at 6 months demonstrated an increase in the complete occlusion rate to 92.9%. No delayed in-stent stenosis was observed, and three aneurysms recurred. Clinical follow-up was completed in 102 patients (92.7%), and favorable outcomes were achieved in 101 (99%) patients at 6 months. Multivariate analysis showed that aneurysm size (p < 0.001) was associated with incomplete aneurysm occlusion at follow-up. CONCLUSION: Stent-assisted coil embolization with open-cell stents is safe and effective for the treatment of paraclinoid aneurysms and provides progressive occlusion without significant in-stent stenosis events.
Authors: F Di Maria; S Pistocchi; F Clarençon; B Bartolini; R Blanc; A Biondi; H Redjem; J Chiras; N Sourour; M Piotin Journal: AJNR Am J Neuroradiol Date: 2015-08-13 Impact factor: 3.825
Authors: Karam Moon; Felipe C Albuquerque; Andrew F Ducruet; R Webster Crowley; Cameron G McDougall Journal: Neurol Res Date: 2014-02-11 Impact factor: 2.448
Authors: Christopher R Durst; Robert M Starke; David Clopton; H Robert Hixson; Paul J Schmitt; Jean M Gingras; Dale Ding; Kenneth C Liu; R Webster Crowley; Mary E Jensen; Avery J Evans; John Gaughen Journal: J Neurointerv Surg Date: 2015-09-09 Impact factor: 5.836
Authors: Christoph J Griessenauer; Ronie L Piske; Carlos E Baccin; Benedito J A Pereira; Arra S Reddy; Ajith J Thomas; Thiago G Abud; Christopher S Ogilvy Journal: Neurosurgery Date: 2017-05-01 Impact factor: 4.654
Authors: Nimer Adeeb; Christoph J Griessenauer; Paul M Foreman; Justin M Moore; Rouzbeh Motiei-Langroudi; Michelle H Chua; Raghav Gupta; Apar S Patel; Mark R Harrigan; Abdulrahman Y Alturki; Christopher S Ogilvy; Ajith J Thomas Journal: World Neurosurg Date: 2017-05-27 Impact factor: 2.104
Authors: Daniel H Fulkerson; Terry G Horner; Troy D Payner; Thomas J Leipzig; John A Scott; Andrew J Denardo; Kathleen Redelman; Julius M Goodman Journal: Neurosurgery Date: 2009-03 Impact factor: 4.654